Evergreen

This study is testing how effective a new vaccine is in preventing respiratory infections caused by the respiratory syncytial virus (RSV).

Respiratory syncytial virus (RSV) is a common seasonal virus that infects the airways of the lungs. Some people, especially older adults or those living with some long-term conditions, can experience serious complications, including inflammation of the lungs of pneumonia.

This international study is being carried out in Greater Manchester by a team of researchers at Manchester University NHS Foundation Trust.